Step Into the Spotlight at the Innovation Exchange
Launching at Advanced Therapies Europe 2025, the Innovation Exchange is a high-impact pitching competition designed to connect pre-Series B biotech innovators with the industry’s leading investors, VCs, and strategic partners. A platform to get noticed, get feedback, and get connected. If you're building the future of cell and gene therapy, this is the moment to stand out.
Join the Waitlist
Sponsored by
Our Finalists
Developing a novel gene therapy technology that cuts complexity and cost and makes AAV manufacturing viable at scale - to reach more patients, more quickly, and in more disease areas.
What Is the Innovation Exchange?
The Innovation Exchange is a curated live pitching session taking place on 4 September in Barcelona — part of the main agenda at Advanced Therapies Europe. Attending startups will pitch in front of the entire conference audience and a selection panel made up of top-tier investors and pharma deal-makers.
Finalists will receive real-time feedback and the opportunity to gain funding, partnerships, and visibility across the global advanced therapies community.
ENTRIES ARE CLOSED!
The Innovation Exchange is open to pre-Series B startups across the cell and gene therapy ecosystem, including:
Fill in a short application form to register your interest. You’ll then receive the full submission requirements & application form by email.
Complete the full submission form by 9 May, outlining your innovation, business model, and what makes your solution stand out.
Want a preview of the ATE community?
See who was in the room this year and the organisations leading the way in advanced therapies.
Download the 2025 Attendee List
)
)
)
)
)
)
)
)
)
)
